<DOC>
	<DOCNO>NCT02767037</DOCNO>
	<brief_summary>Currently , clear diagnostic test use confirm diagnosis Parkinson 's disease , biomarker track progression . Patients Parkinson 's many abnormality autonomic nervous system , may relate Parkinson 's change outside brain . A new device call SudoScan , measure autonomic sweating change , may simple way test autonomic change Parkinson 's . The investigator plan see whether SudoScan identify Parkinson 's disease whether SudoScan abnormality might present even early ( prodromal ) Parkinson 's stage . The investigator assess SudoScan group Parkinson 's patient , normal healthy control , patient non-Parkinson 's neurodegeneration , patient REM sleep behavior disorder ( early/prodromal Parkinson 's state ) . Abnormalities correlate standard autonomic test skin biopsy finding Parkinson 's degeneration peripheral autonomic fiber . If investigator find reliable way diagnose follow Parkinson 's disease , able correctly identify Parkinson 's ( even early stage ) . This improve chance find protective treatment Parkinson 's , prevent false diagnosis provide new marker track disease progression . If successful , investigator aim validate finding large sample Parkinson 's also track change time original cohort</brief_summary>
	<brief_title>SudoScan Biomarker Parkinson 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>1 . PD patient : All meet criterion probable PD , accord new MDS Clinical Diagnostic criterion 2 . NonPD parkinsonism patient : They progressive supranuclear palsy , multiple system atrophy , 'vascular parkinsonism ' corticobasal syndrome . All patient parkinsonism accord UK brain bank criterion , diagnosis one condition make accord goldstandard expert evaluation . No patient meet MDS Criteria probable PD . 3. iRBD patient : All patient polysomnogramconfirmed RBD accord American Academy Sleep Medicine Criteria . Patients free parkinsonism dementia accord neurological examination untreated sleep apnea , epilepsy , abnormality could cause dream enactment behavior . 4 . Controls : These age match ( within 5 year ) sexmatched ( &gt; 90 % concordance ) . All control examination confirm absence parkinsonism , symptom REM sleep behavior disorder , assess RBD1Q expert interview . 1 . Diabetes Mellitus In addition cause autonomic neuropathy , hyperglycemia know interfere result sudomotor scan 2 . Any precede diagnosis autonomic neuropathy ( cause PD ) 3 . Dementia severity sufficient preclude inform consent , MoCA &lt; 23 . 4 . Prescription medication directly alter peripheral autonomic function , include betablockers , sympatholytics ( i.e . clonidine ) nonspecific alphablockers .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>